The purpose of this review is to propose a systematic approach to the assessment of social phobia for monitoring treatment outcome in clinical settings. A selection of measures is available, including questionnaires and structured interviews varying in length, complexity, and content. To design an a
Low dose selegiline (L-Deprenyl) in social phobia
โ Scribed by H. Blair Simpson; Franklin R. Schneier; Randall D. Marshall; Raphael B. Campeas; Donna Vermes; Joao Silvestre; Sharon Davies; Michael R. Liebowitz
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 51 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## This study describes the natural course of social phobia as recalled by a sample of nonclinical subjects and explores, using qualitative research methods, perceived risk factors and factors that may cause changes in its course. Thirtynine respondents with a lifetime diagnosis of social phobia wer
The current study examines levels of anxiety sensitivity among social phobic patients with and without panic attacks. Two-hundred fourteen individuals with a primary diagnosis of social phobia completed the Anxiety Sensitivity Index (ASI) prior to treatment. Social phobics who experienced panic atta
Social phobia, particularly the generalized form, is strongly familial. Given the probable continuity from extremes of normative personality (e.g., shyness) to social phobia to personality disorder (e.g., avoidant personality disorder), it is unlikely that social phobia itself, at the level of an Ax